- Joined
- Aug 8, 2013
- Messages
- 172
- Reaction score
- 32
Let's gather all the new drugs that we should know for the exam so we don't miss out on them while studying on our own. Please, add any that are either NEW or NOT in FA, but are HY. It will be greatly appreciated by many especially those near exam. So, please lets contribute:
I'll add the ones I came across in FA and will add more later:
Micro:
Plasmodium
-if resistant, use mefloquine or atovaquone/proguanil
Trypanosoma cruzi
Rx-Benznidazole
Babesia
-Atovaquone + azithromycin
Cryptosporidium
nitazoxanide in immunocompetent hosts
5th gen Cephalo=
5th generation (ceftaroline)—broad gram-positive and gram-negative organism coverage, including MRSA; does not cover Pseudomonas.
Newer carbapenems include ertapenem (limited Pseudomonas coverage) and doripenem.
Cidofovir
TOXICITY Nephrotoxicity (coadminister with probenecid and IV saline to toxicity).
NRTIs-
Emtricitabine (FTC)
----------------------------------------
IMMUNO ---
Basiliximab -
Monoclonal antibody - blokcs IL 2R -
For Kidney transplant +R
ejection prophylaxis.
Tox-Edema, hypertension, tremor
Cancer therapy Antibodies
Alemtuzumab targets CD52 for CLL
Bevacizumab targets VEGF ---for Colorectal cancer, renal cell carcinoma
Cetuximab targets EGFR ----For Stage IV colorectal cancer, head and neck cancer
Palivizumab targets RSV F protein for RSV prophylaxis for high-risk infants
I'll add the ones I came across in FA and will add more later:
Micro:
Plasmodium
-if resistant, use mefloquine or atovaquone/proguanil
Trypanosoma cruzi
Rx-Benznidazole
Babesia
-Atovaquone + azithromycin
Cryptosporidium
nitazoxanide in immunocompetent hosts
5th gen Cephalo=
5th generation (ceftaroline)—broad gram-positive and gram-negative organism coverage, including MRSA; does not cover Pseudomonas.
Newer carbapenems include ertapenem (limited Pseudomonas coverage) and doripenem.
Cidofovir
TOXICITY Nephrotoxicity (coadminister with probenecid and IV saline to toxicity).
NRTIs-
Emtricitabine (FTC)
----------------------------------------
IMMUNO ---
Basiliximab -
Monoclonal antibody - blokcs IL 2R -
For Kidney transplant +R
ejection prophylaxis.
Tox-Edema, hypertension, tremor
Cancer therapy Antibodies
Alemtuzumab targets CD52 for CLL
Bevacizumab targets VEGF ---for Colorectal cancer, renal cell carcinoma
Cetuximab targets EGFR ----For Stage IV colorectal cancer, head and neck cancer
Palivizumab targets RSV F protein for RSV prophylaxis for high-risk infants
Last edited: